The race continues to test and find the first effective COVID-19 vaccine, and a cell and gene product development facility at UW-Madison is helping to produce a vaccine. Waisman Biomanufacturing announced on Monday they are partnering with Heat Biologics to produce a vaccine for phase 1 and phase 2 clinical trials.
Office of Strategic Communication